VATE
INDUSTRIALSInnovate Corp
AI Insight
What's Moving VATE Today?
No stock-specific AI insight has been generated for VATE yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$3.41$21.30
$18.15
Fundamentals
Market Cap$241M
P/E Ratio—
EPS$-4.24
Dividend Yield—
Dividend / Share—
ROE-19.1%
Profit Margin-4.0%
Debt / Equity—
Trading
Volume71K
Avg Volume (10D)—
Shares Outstanding13.6M
VATE News
22 articles- INNOVATE Announces Successful Closing of Broadcasting Refinancing and Agrees to Partial Sale of BroadcastingYahoo Finance·Jun 1, 2026
- INNOVATE Q1 Loss Narrows Y/Y on Infrastructure, AI Project DemandYahoo Finance·May 27, 2026
- INNOVATE Corp. (VATE): 10 Best Performing NYSE Stocks So Far in 2026Yahoo Finance·May 21, 2026
- INNOVATE Q1 Earnings Call HighlightsMarketbeat·May 15, 2026
- Innovate Corp (VATE) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic Advances ...Yahoo Finance·May 15, 2026
- Innovate Corp (VATE) Q1 2026 Earnings: EPS -$1.29, Revenue $364.8M -- Is the Stock 113.1% Overvalued?GuruFocus·May 14, 2026
- INNOVATE Corp. Announces First Quarter 2026 ResultsYahoo Finance·May 14, 2026
- INNOVATE Corp. to Report First Quarter 2026 Results on May 14thYahoo Finance·Apr 27, 2026
- INNOVATE's Portfolio Company DBM Global to Pay Cash DividendBenzinga·Apr 6, 2026
- INNOVATE’s Portfolio Company DBM Global to Pay Cash DividendYahoo Finance·Apr 6, 2026
- DBM Global to Pay Cash DividendBenzinga·Apr 3, 2026
- MediBeacon® Transdermal GFR Monitor and Reusable Sensor Receive CE Mark Under European Medical Device RegulationYahoo Finance·Mar 31, 2026
- INNOVATE Q4 Earnings Call HighlightsMarketbeat·Mar 26, 2026
- INNOVATE Corp. Announces Fourth Quarter and Full Year 2025 ResultsYahoo Finance·Mar 26, 2026
- INNOVATE Corp. to Report Fourth Quarter and Full Year 2025 Results on March 26thYahoo Finance·Mar 16, 2026
- Transdermal GFR Article Recognized as One of Five 2025 Editors’ Choice Articles by Journal of the American Society of Nephrology (JASN)Yahoo Finance·Feb 10, 2026
- MediBeacon® Next Generation TGFR™ System Receives FDA ApprovalYahoo Finance·Dec 16, 2025
- Shareholders in INNOVATE (NYSE:VATE) are in the red if they invested five years agoYahoo Finance·Dec 9, 2025
- Innovate Corp (VATE) Q3 2025 Earnings Call Highlights: Revenue Surge Amidst Strategic ShiftsYahoo Finance·Nov 13, 2025
- INNOVATE Corp. Announces Third Quarter 2025 ResultsYahoo Finance·Nov 12, 2025
- INNOVATE Corp. to Report Third Quarter 2025 Results on November 12thYahoo Finance·Oct 22, 2025
- MediBeacon receives regulatory approval to sell the Transdermal GFR System in ChinaYahoo Finance·Oct 21, 2025
All 22 articles loaded
Price Data
Open$17.57
Previous Close$18.20
Day High$18.75
Day Low$15.81
52 Week High$21.30
52 Week Low$3.41
52-Week Range
$3.41$21.30
$18.15
Fundamentals
Market Cap$241M
P/E Ratio—
EPS$-4.24
Dividend Yield—
Dividend / Share—
ROE-19.1%
Profit Margin-4.0%
Debt / Equity—
Trading
Volume71K
Avg Volume (10D)—
Shares Outstanding13.6M
About Innovate Corp
INNOVAR Corp. The company is headquartered in New York, New York.
INDUSTRIALSENGINEERING & CONSTRUCTION
Company Details
Security TypeCommon Stock
ExchangeNYSE
CurrencyUSD
Round Lot—
SICENGINEERING & CONSTRUCTION
CIK—
Composite FIGI—
Share Class FIGI—